138 related articles for article (PubMed ID: 9644114)
1. Effects of Lorenzo's Oil on peroxisomes in healthy mice.
De Craemer D; Van den Branden C; Fontaine M; Vamecq J
Prostaglandins Other Lipid Mediat; 1998 Mar; 55(4):237-44. PubMed ID: 9644114
[TBL] [Abstract][Full Text] [Related]
2. Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).
Rasmussen M; Moser AB; Borel J; Khangoora S; Moser HW
Neurochem Res; 1994 Aug; 19(8):1073-82. PubMed ID: 7800117
[TBL] [Abstract][Full Text] [Related]
3. Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid.
Sassa T; Wakashima T; Ohno Y; Kihara A
J Lipid Res; 2014 Mar; 55(3):524-30. PubMed ID: 24489110
[TBL] [Abstract][Full Text] [Related]
4. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
[TBL] [Abstract][Full Text] [Related]
5. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A
Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761
[TBL] [Abstract][Full Text] [Related]
7. Treatment of X-linked adrenoleukodystrophy with Lorenzo's oil.
Moser HW
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):279-80. PubMed ID: 10449544
[No Abstract] [Full Text] [Related]
8. Mutant fruit flies respond to Lorenzo's oil.
Barinaga M
Science; 1999 Jun; 284(5422):1899, 1901. PubMed ID: 10400528
[No Abstract] [Full Text] [Related]
9. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
[TBL] [Abstract][Full Text] [Related]
10. Lorenzo's oil: advances in the treatment of neurometabolic disorders.
Ferri R; Chance PF
Arch Neurol; 2005 Jul; 62(7):1045-6. PubMed ID: 16009756
[No Abstract] [Full Text] [Related]
11. On the mechanism of stimulation of peroxisomal beta-oxidation in rat heart by partially hydrogenated fish oil.
Kvannes J; Eikhom TS; Flatmark T
Biochim Biophys Acta; 1995 Mar; 1255(1):39-49. PubMed ID: 7893736
[TBL] [Abstract][Full Text] [Related]
12. Effect of erucic acid on platelets in patients with adrenoleukodystrophy.
Kickler TS; Zinkham WH; Moser A; Shankroff J; Borel J; Moser H
Biochem Mol Med; 1996 Apr; 57(2):125-33. PubMed ID: 8733890
[TBL] [Abstract][Full Text] [Related]
13. Lorenzo's oil therapy of adrenoleukodystrophy.
DiGregorio VY; Schroeder DJ
Ann Pharmacother; 1995 Mar; 29(3):312-3. PubMed ID: 7606079
[No Abstract] [Full Text] [Related]
14. Erucic acid, a component of Lorenzo's oil and PPAR-δ ligand modifies C6 glioma growth and toxicity of doxorubicin. Experimental data and a comprehensive literature analysis.
Altinoz MA; Bilir A; Elmaci İ
Chem Biol Interact; 2018 Oct; 294():107-117. PubMed ID: 30142312
[TBL] [Abstract][Full Text] [Related]
15. Lorenzo's oil: a reassessment.
Poulos A; Robertson EF
Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809
[No Abstract] [Full Text] [Related]
16. Dietary docosahexaenoic acid has little effect on peroxisomes in healthy mice.
De Craemer D; Pauwels M; Van den Branden C
Lipids; 1996 Nov; 31(11):1157-61. PubMed ID: 8934448
[TBL] [Abstract][Full Text] [Related]
17. Adrenoleukodystrophy: magnetic resonance follow-up after Lorenzo's oil therapy.
Duchesne N; Dufour M; Bouchard G; Grondin P; Lemieux B
Can Assoc Radiol J; 1995 Oct; 46(5):386-91. PubMed ID: 7552831
[TBL] [Abstract][Full Text] [Related]
18. Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible?
Cappa M; Bizzarri C; Giannone G; Aiello C; Di Biase A
J Endocrinol Invest; 2011 Nov; 34(10):753-6. PubMed ID: 21399389
[TBL] [Abstract][Full Text] [Related]
19. A model-based approach to assess the exposure-response relationship of Lorenzo's oil in adrenoleukodystrophy.
Ahmed MA; Kartha RV; Brundage RC; Cloyd J; Basu C; Carlin BP; Jones RO; Moser AB; Fatemi A; Raymond GV
Br J Clin Pharmacol; 2016 Jun; 81(6):1058-66. PubMed ID: 26836218
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.
Moser HW; Raymond GV; Koehler W; Sokolowski P; Hanefeld F; Korenke GC; Green A; Loes DJ; Hunneman DH; Jones RO; Lu SE; Uziel G; Giros ML; Roels F
Adv Exp Med Biol; 2003; 544():369-87. PubMed ID: 14713253
[No Abstract] [Full Text] [Related]
[Next] [New Search]